De Novo DNMTs and DNA Methylation: Novel Insights into Disease Pathogenesis and Therapy from Epigenomics

E-ISSN： 1873-4286|20|11|1812-1818

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.11, 2014-04, pp. : 1812-1818

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epigenomics Poised to Enter Cancer Diagnostics Market with DNA Methylation Marker Technology

Pharmaceutical & Diagnostic Innovation, Vol. 2, Iss. 5, 2004-10 ,pp. : 51-55

Adis International

Access to resources Recommend Favorite

Editorial (Thematic Issue: Novel Perspectives for Parkinson’s Disease Therapy: Insights from the Latest Advances in Disease Pathophysiology, Diagnostic and Experimental Tools and Molecular Targets)

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 8, 2013-12 ,pp. : 1083-1085

Bentham Science Publishers

Access to resources Recommend Favorite

DNA Methylation in the Pathogenesis of Systemic Lupus Erythematosus

Current Pharmacogenomics, Vol. 3, Iss. 1, 2005-03 ,pp. : 73-78

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of DNA Methylation in the Pathogenesis and Treatment of Cancer

Current Clinical Pharmacology, Vol. 7, Iss. 4, 2012-11 ,pp. : 333-340

Bentham Science Publishers

Access to resources Recommend Favorite

DNA Methylation Patterns in Cancer: Novel Prognostic Indicators?

By Frühwald M.C.

American Journal of PharmacoGenomics, Vol. 3, Iss. 4, 2003-01 ,pp. : 245-260

Adis International

Access to resources Recommend Favorite